跳至主要内容
临床试验/DRKS00033175
DRKS00033175招募中不适用

Sleep quality and quality of life with long-term drug therapy for moderate to severe insomnia

Charité-Universitätsmedizin Berlin0 个研究点目标入组 105 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients with chronic insomnia according to the ICSD-3 definition
  • - Insomnia severity moderate to severe (ISI > 14)
  • - Written consent of the patient after verbal and written information
  • - no previous drug therapy for moderate to severe insomnia for at least 3 months

排除标准

  • - Patients who have already received any type of therapy for moderate to severe insomnia without subjective and objective benefit
  • - Patients with severe, life-limiting illnesses and symptoms that significantly impair sleep, independent of insomnia, such as malignant diseases, pain disorders, unstable or exacerbated illnesses, etc.
  • - Alcohol or drug abuse

研究者

相似试验